© 1993 Oxford University Press
research-article |
Evaluation of 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites+
Analytisch-biologisches Forschungslabor Prof. Dr Med. F.Adlkofer Goethestraße 20, D-8000 Munich, Germany
1Ökolab, Gesellschaft für Umweltanalytik Hasnerstraße 124a, A-1160 Vienna, Austria
The potential endogenous nitrosation of nicotine and cotinine to yield 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid (Iso-NNAC) has been studied in smokers and non-smokers. Following i.v. administration of 100 µg Iso-NNAC to rats, excretion in urine (67.4 ± 25.4%) and feces (6.1± 1.6%) occurred within 24 h. The urinary excretion of nitrate, nicotine, cotinine and Iso-NNAC were determined in 24 h urine samples from 19 smokers and 10 non-smokers. Iso-NNAC excretion was found on four occasions (44, 65, 74 and 163 ng/day) in smokers; non-smokers did not excrete Iso-NNAC. Oral administration of nicotine (n = 8; 1240 mg) and cotinine (n = 3; 4060 mg) to abstinent smokers did not result in Iso-NNAC excretion, even after oral nitrate (150mg) supplementation. However, Iso-NNAC was found in cigarette tobacco (10330 ng/g) and mainstream cigarette smoke (1.15.5 ng/cig.). Our studies suggest that the occasional presence of Iso-NNAC in smokers' urine results from exogenous exposure to the preformed compound in mainstream cigarette smoke and not from endogenous nitrosation of nicotine and its metabolites.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Scherer and E. Richter Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal Human and Experimental Toxicology, August 1, 1997; 16(8): 449 - 459. [Abstract] [PDF] |
||||

